tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ETON is currently covered by 4 analysts with an average price target of $56.14. This is a potential upside of -$3.04 (-5.14%) from yesterday's end of day stock price of $59.18.
Eton Pharmaceuticals's activity chart (see below) currently has 33 price targets and 37 ratings on display. The stock rating distribution of ETON is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 87.17% with an average time for these price targets to be met of 306.44 days.
Highest price target for ETON is $70, Lowest price target is $31, average price target is $56.14.
Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 14-Aug-2026. First documented stock forecast 15-Oct-2021.
Currently out of the existing stock ratings of ETON, 12 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Sep-2024
$70
$12.32 (21.36%)
$65
1 months 15 days ago
(14-Aug-2026)
9/11 (81.82%)
$11.14 (18.93%)
195
Buy Since 20-Mar-2026
$70
$12.32 (21.36%)
$31
1 months 15 days ago
(14-Aug-2026)
4/5 (80%)
$11.14 (18.93%)
251
Buy Since 17-Jul-2026
$68
$10.32 (17.89%)
$60
1 months 15 days ago
(14-Aug-2026)
1/2 (50%)
$9.14 (15.53%)
31
Buy Since 06-May-2024
$62
$4.32 (7.49%)
$35
2 months 1 days ago
(28-Jul-2026)
10/10 (100%)
$15.34 (32.88%)
162
Buy Since 21-Mar-2023
$10
$-47.68 (-82.66%)
$10
2 years 9 months 18 days ago
(11-Dec-2023)
3/3 (100%)
$6.07 (154.45%)
467
What is ETON (Eton Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on ETON (Eton Pharmaceuticals)?
Which analyst has the current lower performing score on ETON (Eton Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ETON (Eton Pharmaceuticals)?
Which analyst is the currently most bullish on ETON (Eton Pharmaceuticals)?
Which analyst is the currently most reserved on ETON (Eton Pharmaceuticals)?
